Anna Solarska-Polchlopek
Overview
Explore the profile of Anna Solarska-Polchlopek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zagorowicz E, Cichoz-Lach H, Kopertowska-Majchrzak M, Eder P, Stawczyk-Eder K, Talar-Wojnarowska R, et al.
Adv Clin Exp Med
. 2023 May;
33(1):69-77.
PMID: 37166016
Background: Vedolizumab is recommended as a first-line biological treatment, along with other biological drugs, in ulcerative colitis (UC) patients in whom conventional therapy failed and as a second-line biological treatment...
2.
Eder P, Klopocka M, Cichoz-Lach H, Talar-Wojnarowska R, Kopertowska-Majchrzak M, Michalak A, et al.
Therap Adv Gastroenterol
. 2023 Feb;
16:17562848231151295.
PMID: 36818601
Background: Vedolizumab is a gut-selective anti-lymphocyte trafficking agent used to treat ulcerative colitis (UC) and Crohn's disease. Objectives: We aimed to evaluate the effectiveness, safety, and durability of the therapeutic...
3.
Cichoz-Lach H, Michalak A, Kopertowska-Majchrzak M, Eder P, Stawczyk-Eder K, Waszak K, et al.
Therap Adv Gastroenterol
. 2021 Sep;
14:17562848211036456.
PMID: 34484422
Background: Vedolizumab, a humanized antibody targeting the αβ integrin, was proven to be effective in the treatment of moderate-to-severe ulcerative colitis (UC) in randomized clinical trials. The aim of the...
4.
The prognostic value of renal dysfunction in patients with chronic heart failure: 12-month follow-up
Roik M, Starczewska M, Stawicki S, Solarska-Polchlopek A, Warszawik O, Oreziak A, et al.
Kardiol Pol
. 2006 Aug;
64(7):704-11.
PMID: 16886127
Introduction: Renal function assessment is an important element of management and therapeutic decision-making in patients with chronic heart failure (CHF). Aim: To evaluate the prognostic value of renal dysfunction in...